Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Orthopedic Bone Cement
... at a CAGR of 4.9% over the analysis period 2024-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$944.8 Million by the ... Read More
-
Benign Prostatic Hyperplasia (BPH) Drugs
... Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Alpha-Blockers, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.4 Billion by ... Read More
-
Dermatology Diagnostic Devices
... at a CAGR of 9.2% over the analysis period 2024-2030. Lasers, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$19.2 Billion by the end of the ... Read More
-
Cardiovascular Disease Monitoring and Diagnostic Devices
... reach US$3.6 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. ECG Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach ... Read More
-
Airway Clearance Systems
... at a CAGR of 4.7% over the analysis period 2024-2030. Positive Expiratory Pressure (PEP) Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$396.2 Million by ... Read More
-
Adult Stores
... CAGR of 6.8% over the analysis period 2024-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$34.6 Billion by the end of the analysis ... Read More
-
Emergency Contraceptive Pills
... at a CAGR of 2.4% over the analysis period 2024-2030. Combination Pills, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$484.2 Million by the end of ... Read More
-
Rheumatoid Arthritis Therapeutics
... at a CAGR of 4.1% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$28.0 Billion by the end of the ... Read More
-
Breast Cancer Therapeutics
... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Orthopedic Prosthetic Implants
... at a CAGR of 4.5% over the analysis period 2024-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Anti-Infectives
... 6.2% over the analysis period 2024-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. Growth ... Read More
-
Bipolar Disorder Therapeutics
... at a CAGR of 3.4% over the analysis period 2024-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Pancreatic Cancer Drugs
... at a CAGR of 4.6% over the analysis period 2024-2030. Exocrine, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$3.2 Billion by the end of the ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More
-
Aesthetic Services
... CAGR of 7.0% over the analysis period 2024-2030. Surgical, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$17.1 Billion by the end of the analysis period. ... Read More
-
Hyperpigmentation Disorders Treatment
... at a CAGR of 5.9% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Orthopedic Digit Implants
... at a CAGR of 5.3% over the analysis period 2024-2030. Metatarsal Joint Implants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$202.2 Million by the end ... Read More
-
Periodontal Therapeutics
... CAGR of 8.6% over the analysis period 2024-2030. Systemic Antibiotics, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$623.3 Million by the end of the analysis ... Read More
-
Rheumatology Therapeutics
... CAGR of 3.2% over the analysis period 2024-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More
-
Skin Allergy Therapeutics
... at a CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$492.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market in the U.S. ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Respiratory Protection Equipment
... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More
-
Corticosteroids Therapy
... CAGR of 4.6% over the analysis period 2024-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.1 Billion by the end of the analysis period. ... Read More
-
Lumbosacral Orthosis (LSO)
... at a CAGR of 3.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$128.7 Million While China is Forecast to Grow at 5.6% CAGR The Lumbosacral Orthosis (LSO) market in the U.S. ... Read More
Research Assistance
